Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• JemalASiegelRXuJWardECancer statistics, 2010CA Cancer J Clin201060527730020610543
   PubMed Web of Science ®Google Scholar
• MohammedFEsophageal cancerN Engl J Med20043501313631364 author reply 1363–1364
   PubMedGoogle Scholar
• SznolMChenLAntagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancerClin Cancer Res20131951021103423460533
   PubMed Web of Science ®Google Scholar
• PostowMACallahanMKWolchokJDImmune checkpoint blockade in cancer therapyJ Clin Oncol201533171974198225605845
   PubMed Web of Science ®Google Scholar
• McDermottDFAtkinsMBPD-1 as a potential target in cancer therapyCancer Med20132566267324403232
   PubMed Web of Science ®Google Scholar
• ZouWChenLInhibitory B7-family molecules in the tumour microenvironmentNat Rev Immunol20088646747718500231
   PubMed Web of Science ®Google Scholar
• PardollDMThe blockade of immune checkpoints in cancer immunotherapyNat Rev Cancer201212425226422437870
   PubMed Web of Science ®Google Scholar
• ChenJLiGMengHUpregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomasCancer Immunol Immunother201261110110821853301
   PubMed Web of Science ®Google Scholar
• DongHStromeSESalomaoDRTumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionNat Med20028879380012091876
   PubMed Web of Science ®Google Scholar
• LoteHCafferkeyCChauIPD-1 and PD-L1 blockade in gastrointestinal malignanciesCancer Treat Rev2015411089390326412280
   PubMedGoogle Scholar
• ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• MantelNHaenszelWStatistical aspects of the analysis of data from retrospective studies of diseaseJ Natl Cancer Inst195922471974813655060
   PubMed Web of Science ®Google Scholar
• BakerWLWhiteCMCappelleriJCKlugerJColemanCIHealth Outcomes, Policy, and Economics (HOPE) Collaborative GroupUnderstanding heterogeneity in meta-analysis: the role of meta-regressionInt J Clin Pract200963101426143419769699
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• YuanJZhangJZhuYProgrammed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significanceOncotarget2016726396713967927191996
   PubMedGoogle Scholar
• WangLAWeiXLiQChenLThe prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonographyTumour Biol20163767327733226671554
   PubMedGoogle Scholar
• WangLRenFWangQSignificance of programmed death ligand 1 (PD-L1) immunohistochemical expression in colorectal cancerMol Diagn Ther201620217518126891728
   PubMedGoogle Scholar
• LengCLiYQinJRelationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8(+) T cellsOncol Rep201635269970826718132
   PubMed Web of Science ®Google Scholar
• DunnePDMcArtDGO’ReillyPGImmune-derived PD-L1 gene expression defines a subgroup of stage II/III colorectal cancer patients with favorable prognosis who may be harmed by adjuvant chemotherapyCancer Immunol Res20164758259127197062
   PubMedGoogle Scholar
• DongMWangHYZhaoXXExpression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinomaHum Pathol201653253426980034
   PubMed Web of Science ®Google Scholar
• ChenMFChenPTChenWCLuMSLinPYLeeKDThe role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppressionOncotarget2016777913792426761210
   PubMedGoogle Scholar
• ChenKChengGZhangFPrognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinomaOncotarget2016721307723078027120796
   PubMedGoogle Scholar
• BögerCBehrensHMMathiakMKrugerSKalthoffHRockenCPD-L1 is an independent prognostic predictor in gastric cancer of Western patientsOncotarget2016717242692428327009855
   PubMed Web of Science ®Google Scholar
• ZhangLQiuMJinYProgrammed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factorsInt J Clin Exp Pathol201589110841109126617827
   PubMed Web of Science ®Google Scholar
• UmemotoYOkanoSMatsumotoYPrognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomyJ Gastroenterol2015501657524509608
   PubMed Web of Science ®Google Scholar
• TamuraTOhiraMTanakaHProgrammed death-1 ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II/III gastric cancerAnticancer Res201535105369537626408698
   PubMed Web of Science ®Google Scholar
• QingYLiQRenTUpregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancerDrug Des Devel Ther20159901909
   PubMed Web of Science ®Google Scholar
• LimYJKohJKimKHigh ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapyRadiother Oncol2015117116517026235847
   PubMed Web of Science ®Google Scholar
• LimSHHongMAhnSChanges in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerEur J Cancer2016521926623522
   PubMed Web of Science ®Google Scholar
• KanGDongWThe expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathologyEur Rev Med Pharmacol Sci201519163063307126367730
   PubMed Web of Science ®Google Scholar
• GengYWangHLuCExpression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significanceInt J Clin Oncol201520227328124804867
   PubMed Web of Science ®Google Scholar
• EtoSYoshikawaKNishiMProgrammed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resectionGastric Cancer201619246647126210691
   PubMed Web of Science ®Google Scholar
• LiangMLiJWangDT-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China’s Heilongjiang provinceTumour Biol2014351556023873101
   PubMedGoogle Scholar
• KimJWNamKHAhnSHPrognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancerGastric Cancer2016191425225424150
   PubMed Web of Science ®Google Scholar
• HouJYuZXiangRCorrelation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancerExp Mol Pathol201496328429124657498
   PubMed Web of Science ®Google Scholar
• SongMChenDLuBPTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancerPLoS One201386e6582123785454
   PubMedGoogle Scholar
• ShiSJWangLJWangGDB7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cellsPLoS One2013810e7601224124529
   PubMed Web of Science ®Google Scholar
• DroeserRAHirtCViehlCTClinical impact of programmed cell death ligand 1 expression in colorectal cancerEur J Cancer20134992233224223478000
   PubMed Web of Science ®Google Scholar
• ZengZShiFZhouLUpregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinomaPLoS One201169e2362121912640
   PubMed Web of Science ®Google Scholar
• LoosMLangerRSchusterTClinical significance of the costimulatory molecule B7-H1 in Barrett carcinomaAnn Thorac Surg20119141025103121440117
   PubMed Web of Science ®Google Scholar
• WangLMaQChenXGuoKLiJZhangMClinical significance of B7-H1 and B7-1 expressions in pancreatic carcinomaWorld J Surg20103451059106520145927
   PubMed Web of Science ®Google Scholar
• GaoQWangXYQiuSJOverexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinomaClin Cancer Res200915397197919188168
   PubMed Web of Science ®Google Scholar
• ChenXLYuanSXChenCMaoYXXuGWangXYExpression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significanceAi Zheng2009281213281332 Chinese19958630
   PubMedGoogle Scholar
• SunJXuKWuCPD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodiesTissue Antigens2007691192717212704
   PubMed Web of Science ®Google Scholar
• NomiTShoMAkahoriTClinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancerClin Cancer Res20071372151215717404099
   PubMed Web of Science ®Google Scholar
• WuCZhuYJiangJZhaoJZhangXGXuNImmunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significanceActa Histochem20061081192416530813
   PubMed Web of Science ®Google Scholar
• MellmanICoukosGDranoffGCancer immunotherapy comes of ageNature2011480737848048922193102
   PubMed Web of Science ®Google Scholar
• SharmaPAllisonJPThe future of immune checkpoint therapyScience20153486230566125838373
   PubMed Web of Science ®Google Scholar
• HuangBChenLBaoCThe expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysisOnco Targets Ther201582617262526451118
   PubMed Web of Science ®Google Scholar
• WuPWuDLiLChaiYHuangJPD-L1 and survival in solid tumors: a meta-analysisPLoS One2015106e013140326114883
   PubMed Web of Science ®Google Scholar